We are live on ! Find out more
KBG

Kahn Brothers Group Portfolio holdings

AUM $564M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
-2.13%
1 Year Est. Return
+25.3%
3 Year Est. Return
+38.07%
5 Year Est. Return
+72.96%
10 Year Est. Return
+308.37%
AUM
$641M
AUM Growth
-$41.1M
Cap. Flow
-$9.95M
Cap. Flow %
-1.55%
Top 10 Hldgs %
83.4%
Holding
45
New
2
Increased
7
Reduced
24
Closed
2

Top Buys

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$1.6M
2
GSK icon
GSK
GSK
+$668K
3
C icon
Citigroup
C
+$390K
4
CMCSA icon
Comcast
CMCSA
+$214K
5
BAC icon
Bank of America
BAC
+$165K

Top Sells

Rank Stock Value
1
PTEN icon
Patterson-UTI
PTEN
+$2.86M
2
BP icon
BP
BP
+$2.56M
3
HLN icon
Haleon
HLN
+$1.98M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.2M
5
MRK icon
Merck
MRK
+$1.06M

Sector Composition

Rank Sector Weight
1 Financials 34.89%
2 Healthcare 32.93%
3 Energy 18.94%
4 Consumer Staples 5.66%
5 Technology 4.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLG
1
Flagstar Bank National Association
FLG
$6.21B
$71.4M 11.14%
2,097,966
-19,591
-0.9% -$709K
BP icon
2
BP
BP
$108B
$68.7M 10.71%
1,773,634
-68,857
-4% -$2.56M
MRK icon
3
Merck
MRK
$315B
$65.8M 10.26%
638,793
-9,878
-2% -$1.06M
AGO icon
4
Assured Guaranty
AGO
$3.76B
$61.9M 9.65%
1,022,139
-16,795
-2% -$997K
PTEN icon
5
Patterson-UTI
PTEN
$3.8B
$50.4M 7.86%
3,639,719
-195,748
-5% -$2.86M
C icon
6
Citigroup
C
$217B
$50M 7.8%
1,215,684
+8,878
+0.7% +$390K
BMY icon
7
Bristol-Myers Squibb
BMY
$124B
$49.5M 7.72%
851,699
-19,545
-2% -$1.2M
GSK icon
8
GSK
GSK
$104B
$46.5M 7.25%
1,282,289
+18,831
+1% +$668K
SEB icon
9
Seaboard Corp
SEB
$4.34B
$35.6M 5.55%
9,474
-86
-0.9% -$313K
PFE icon
10
Pfizer
PFE
$143B
$35M 5.46%
1,055,759
-10,332
-1% -$365K
MBI icon
11
MBIA
MBI
$333M
$34.7M 5.41%
4,809,384
-29,111
-0.6% -$242K
VOXX
12
DELISTED
VOXX International Corporation Class A
VOXX
$23.1M 3.6%
2,892,612
-31,554
-1% -$284K
HLN icon
13
Haleon
HLN
$44.5B
$8.6M 1.34%
1,032,464
-237,974
-19% -$1.98M
IDT icon
14
IDT Corp
IDT
$1.57B
$7.7M 1.2%
349,063
-4,052
-1% -$95.4K
BB icon
15
BlackBerry
BB
$5.27B
$6.5M 1.01%
1,380,056
-26,189
-2% -$129K
GNE icon
16
Genie Energy
GNE
$369M
$4.38M 0.68%
297,512
-4,552
-2% -$66.1K
WBS icon
17
Webster Financial
WBS
$12.3B
$4.29M 0.67%
106,412
– –
NVS icon
18
Novartis
NVS
$293B
$2.2M 0.34%
21,578
– –
HOLX
19
DELISTED
Hologic
HOLX
$1.98M 0.31%
28,491
-1,544
-5% -$117K
XOM icon
20
ExxonMobil
XOM
$611B
$1.81M 0.28%
15,437
+1,482
+11% +$163K
CSX icon
21
CSX Corp
CSX
$94.3B
$1.55M 0.24%
+50,428
New +$1.6M
BAC icon
22
Bank of America
BAC
$430B
$1.04M 0.16%
38,073
+5,592
+17% +$165K
OGN icon
23
Organon & Co
OGN
$3.55B
$892K 0.14%
51,346
-8,452
-14% -$176K
VTRS icon
24
Viatris
VTRS
$20.1B
$709K 0.11%
68,988
-2,794
-4% -$29.1K
CVX icon
25
Chevron
CVX
$373B
$548K 0.09%
3,248
– –
1
2

Similar funds

AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
TCP
ThornTree Capital Partners Boston, Massachusetts $564M AUM 36.37% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $565M AUM
KF
KKM Financial Chicago, Illinois $563M AUM 28.2% 1-Year Est. Return
AAS
Asset Allocation Strategies Farmington, Michigan $563M AUM 15.65% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return

Kahn Brothers Group's Q3 2023 Portfolio in Review

As of Q3 2023, Kahn Brothers Group held 45 positions worth $641M, down 6% from $682M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Kahn Brothers Group's Q3 2023 filing shows 2 new, 7 increased, 24 reduced and 2 closed positions. Its largest new stake was CSX Corp: 50,428 shares worth $1.55M. The largest sale was Patterson-UTI, an estimated $2.86M.

By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Energy.

  • Kahn Brothers Group's largest Q3 2023 buy was CSX Corp: 50,428 shares worth $1.55M.
  • Kahn Brothers Group added most to GSK in Q3 2023, an estimated $668K increase.
  • Kahn Brothers Group's biggest Q3 2023 reduction was Patterson-UTI, cutting an estimated $2.86M.
  • Kahn Brothers Group fully exited Hope Bancorp in Q3 2023, selling an estimated $261K.
  • Kahn Brothers Group's ten largest holdings make up 83% of its $641M portfolio in Q3 2023.
  • Kahn Brothers Group opened 2 new positions and closed 2 in Q3 2023.
  • Kahn Brothers Group's portfolio value fell 6% quarter-over-quarter to $641M.

Based on Kahn Brothers Group's 13F filing for Q3 2023, filed 13 Nov 2023.